Cargando…
Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer
BACKGROUND: The systemic immune‐inflammation index (SII) is correlated with patient survival in various types of solid tumors. However, only a few studies have focused on the prognostic value of the SII in patients with surgically resected non‐small cell lung cancer (NSCLC). METHODS: This study was...
Autores principales: | Guo, Wei, Cai, Songhua, Zhang, Fan, Shao, Fei, Zhang, Guochao, Zhou, Yang, Zhao, Liang, Tan, Fengwei, Gao, Shugeng, He, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449249/ https://www.ncbi.nlm.nih.gov/pubmed/30734516 http://dx.doi.org/10.1111/1759-7714.12995 |
Ejemplares similares
-
Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma
por: Gao, Yibo, et al.
Publicado: (2019) -
Preoperative systemic immune-inflammation index and prognostic nutritional index predict prognosis of patients with pulmonary neuroendocrine tumors after surgical resection
por: He, Huayu, et al.
Publicado: (2020) -
Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection
por: Jomrich, Gerd, et al.
Publicado: (2019) -
Association between systemic immune-inflammation index (SII) and survival outcome in patients with primary glioblastoma
por: Yang, Chao, et al.
Publicado: (2023) -
Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2020)